Role of Adipose Derived Stem Cells Secretome Biotherapeutic for Breast Cancer Treatment
Loading...
Date
item.page.authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Adipose derived mesenchymal stem cells are increasingly applied in regenerative medicine. However, there are several risks and challenges associated with the use of these stem cells for cancer treatment such as tumorigenesis, adverse immune response, clinical efficacy and safety. This raises the need for cell free therapeutic. Stem cell conditioned medium is cells free bio-therapeutic that has been used for regenerative and tissue repair applications. Stem cell secretions are known to retard proliferation of many cancer cell types. However there is a need to validate the anti-cancer potential of stem cell secretome to use it as bio-therapeutic for cancer treatment. We hypothesized that freeze dried stem cell conditioned medium would induce apoptosis in cancer cells upon increasing doses. The hypothesis stems from the fact that, stem cell secretions such as Dkk1, soluble growth factors and exosomes inhibits tumor growth.
newlineTo address the main clinical concern in cancer treatment which is resistance to therapeutics, we tested the hypothesis in breast cancer in vitro and in vivo models. Breast cancer cells are known to have molecular charactersistics of therapeutic resistant phenotypes such as cancer stemness, drug efflux and escape from immune surveillance. The anti-cancer efficacy was evaluated on two breast cancer types, triple negative breast cancer (TNBC) and Luminal A. At 20mg/ml and above secretome elicits dose dependent apoptotic effect on both the breast cancer types. 70 mg/ml of secretome that induce 90±10% apoptosis in TNBC cells significantly decreased cancer stem cells with CD44+/CD24- phenotype, MDR1+ and PDL-1+ cells. In Luminal A type 70 mg/ml induced 80±10% apoptosis and increased CD44+/CD24- cells with no significant effect on MDR1+ and PDL-1+ cells.
newlineBased on the therapeutic response, Luminal A is more clinically responsive to hormone therapy. However upon developing therapeutic 4
newline
newline
newline